Kinnate Biopharma Inc. Profile Avatar - Palmy Investing

Kinnate Biopharma Inc.

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma…

Biotechnology
US, San Francisco [HQ]

News

Theses · Events · Sentiments
End of KNTE's Analysis
CIK: 1797768 CUSIP: 49705R105 ISIN: US49705R1059 LEI: - UEI: -
Secondary Listings
KNTE has no secondary listings inside our databases.